AXEVIL Capital

Abnormal AI Stock

Private company — Abnormal AI is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.

Status source: AXEVIL investment team

$15.54 per share (AXEVIL consensus estimate)

Source: AXEVIL consensus of recent secondary transactions · as of 11 August 2026

Valuation: $3.42B

Source: D, August 2024 — post-money $5.07B

Data last updated: 11 August 2026

About Abnormal AI

Behavioral-AI threat protection platform that uses artificial intelligence to prevent email attacks and business email compromise. Its latest primary round, a $250M Series D, closed in August 2024 at a $5.1B valuation; annual recurring revenue has surpassed $200M, growing over 100%.

  • Sector: Cybersecurity
  • Headquarters: San Francisco, USA
  • Founded: 2018

Funding rounds

DateRoundPrice / sharePost-money valuation
6 August 2024D$23.16$5.07B
10 May 2022C$19.62$4B
18 November 2020B$3.27$615M
9 November 2019A$0.82$131M

Frequently asked questions

Can I buy Abnormal AI stock?

Not on a public exchange — Abnormal AI is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.

How much is one Abnormal AI share?

A private company has no single official price. AXEVIL's consensus estimate is $15.54 per share as of 11 August 2026. Its most recent round implied a post-money valuation of $5.07B (August 2024).

When will Abnormal AI IPO?

No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.

Is Abnormal AI publicly traded?

No. Abnormal AI is a private company and its shares are not listed on any public exchange.

Similar companies

Risk disclosure

Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Valuations and share prices shown here are AXEVIL estimates built from primary sources — filings, announced rounds and completed secondary transactions — not quoted market prices, and they can be revised. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.

Full legal disclosures · All companies